Welcome to Simcyp


population based pharmacokinetic modelling and simulation

home > news > 2012 > july > memorial sloan kettering cancer centre obtains simcyp licenses


Memorial Sloan Kettering Cancer Centre obtains Simcyp licenses

Simcyp News RSS

Date: 06 Jul 2012

Simcyp is pleased to announce that the Memorial Sloan Kettering Cancer Centre, New York, has signed a not-for-profit license agreement with Simcyp. The Simcyp Population-based Simulator and Simcyp Paediatric will be used for research purposes in the Department of Molecular  Pharmacology and Chemistry.


box top

Workshops


Please click here to view our upcoming workshops.
see more
Publications Need more help?

Consortium members and associates include: